Elanco Animal Health Incorporated [ELAN] is -21.69% lower this YTD. Is it still time to buy?

Elanco Animal Health Incorporated [NYSE: ELAN] closed the trading session at $9.57 on 03/10/23. The day’s price range saw the stock hit a low of $9.40, while the highest price level was $10.05. The company report on March 9, 2023 that Elanco to Participate in the Barclays Global Healthcare Conference.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Barclays Global Healthcare Conference on March 14-15, 2023. Todd Young, executive vice president and CFO, will participate in a fireside chat on Tuesday, March 14 at 8:30 a.m. ET.

A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.

The stocks have a year to date performance of -21.69 percent and weekly performance of -13.78 percent. The stock has been moved at -31.89 percent over the last six months. The stock has performed -28.26 percent around the most recent 30 days and changed -23.87 percent over the most recent 3-months.

If compared to the average trading volume of 6.89M shares, ELAN reached to a volume of 12195993 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Elanco Animal Health Incorporated [ELAN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $15.56 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for Elanco Animal Health Incorporated shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on August 18, 2022. While these analysts kept the previous recommendation, JP Morgan dropped their target price from $28 to $24. The new note on the price target was released on August 16, 2022, representing the official price target for Elanco Animal Health Incorporated stock. Previously, the target price had yet another drop from $32 to $19, while Goldman kept a Sell rating on ELAN stock.

The Average True Range (ATR) for Elanco Animal Health Incorporated is set at 0.47, with the Price to Sales ratio for ELAN stock in the period of the last 12 months amounting to 1.13. The Price to Book ratio for the last quarter was 0.64, with the Price to Cash per share for the same quarter was set at 0.66. Price to Free Cash Flow for ELAN in the course of the last twelve months was 15.78 with Quick ratio for the last quarter at 1.00.

ELAN stock trade performance evaluation

Elanco Animal Health Incorporated [ELAN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.78. With this latest performance, ELAN shares dropped by -28.26% in over the last four-week period, additionally sinking by -31.89% over the last 6 months – not to mention a drop of -64.05% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELAN stock in for the last two-week period is set at 22.84, with the RSI for the last a single of trading hit 15.29, and the three-weeks RSI is set at 28.65 for Elanco Animal Health Incorporated [ELAN]. The present Moving Average for the last 50 days of trading for this stock 12.58, while it was recorded at 10.36 for the last single week of trading, and 15.36 for the last 200 days.

Elanco Animal Health Incorporated [ELAN]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Incorporated [ELAN] shares currently have an operating margin of +6.34 and a Gross Margin at +43.55. Elanco Animal Health Incorporated’s Net Margin is presently recorded at -9.91.

Return on Equity for this stock declined to -5.89, with Return on Assets sitting at -2.76.

Elanco Animal Health Incorporated’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.90.

Earnings per share (EPS) analysis for Elanco Animal Health Incorporated [ELAN] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Incorporated go to 7.00%.

Elanco Animal Health Incorporated [ELAN]: Insider Ownership positions

There are presently around $4,656 million, or 99.10% of ELAN stock, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 84,775,075, which is approximately 59.949% of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 45,691,838 shares of the stock with an approximate value of $437.27 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $315.65 million in ELAN stock with ownership of nearly 8.415% of the company’s market capitalization.

Positions in Elanco Animal Health Incorporated stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 223 institutional holders increased their position in Elanco Animal Health Incorporated [NYSE:ELAN] by around 113,466,509 shares. Additionally, 222 investors decreased positions by around 92,054,222 shares, while 52 investors held positions by with 280,950,407 shares. The mentioned changes placed institutional holdings at 486,471,138 shares, according to the latest SEC report filing. ELAN stock had 70 new institutional investments in for a total of 4,099,237 shares, while 78 institutional investors sold positions of 16,808,460 shares during the same period.


Please enter your comment!
Please enter your name here